Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Egfr-Risk'

Egfr-Risk published presentations and documents on DocSlides.

Targeting EGFR Exon 20 insertions
Targeting EGFR Exon 20 insertions
by unita
Gregory J. Riely. November 2021. What about those ...
Anti-EGFR induced skin
Anti-EGFR induced skin
by berey
toxicity. ESDO Learning Bytes 2021. Dr Violaine RA...
EGFR Mutation in Lung Adenocarcinoma (ADC)
EGFR Mutation in Lung Adenocarcinoma (ADC)
by QuietConfidence
Ana Rima. Lung Cancer: Incidence and Mortality. Ne...
Crystal digital PCR for detection and quantification of circulating EGFR mutations in advanced non-
Crystal digital PCR for detection and quantification of circulating EGFR mutations in advanced non-
by jasmine
Cécile Jovelet. Postdocoral. . fellow. Translati...
The EGFR Signaling Pathway
The EGFR Signaling Pathway
by cady
EGF. Epidermal Growth Factor (EGF). Binds to . Epi...
EGFR-Mutated NSCLC and CNS Involvement: the Conundrum
EGFR-Mutated NSCLC and CNS Involvement: the Conundrum
by pasty-toler
This program will include a discussion of off-lab...
EGFR-Mutated Advanced NSCLC
EGFR-Mutated Advanced NSCLC
by sherrill-nordquist
The Coming Paradigm Shift. Faculty. Suresh S. Ram...
Best Practices in Nursing Management of EGFR Inhibitor Rash
Best Practices in Nursing Management of EGFR Inhibitor Rash
by olivia-moreira
Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pr...
Audit of EGFR mutation testing in patients with proven Non-
Audit of EGFR mutation testing in patients with proven Non-
by aaron
On behalf of the North of England Cancer Network ...
No Does the New EPOC trial eliminate anti-EGFR antibodies a
No Does the New EPOC trial eliminate anti-EGFR antibodies a
by sherrill-nordquist
The New EPOC Study. Randomi. ze. Surgery. Oxalipl...
CD3-EGFR Probody™ T Cell-engaging Bispecific Induces Tumo
CD3-EGFR Probody™ T Cell-engaging Bispecific Induces Tumo
by karlyn-bohler
Increases . Safety Window in Preclinical Studies....
Mechanisms of resistance to EGFR
Mechanisms of resistance to EGFR
by conchita-marotz
TKI. s. . and . related. . treatment . strategi...
Glomerular Filtration Rate, Chronic Kidney Disease, and Transplant Eligibility
Glomerular Filtration Rate, Chronic Kidney Disease, and Transplant Eligibility
by kaiden438
Assumed background knowledge: basic nephron physio...
Renal function in the PROUD study, a pragmatic open label randomised trial of
Renal function in the PROUD study, a pragmatic open label randomised trial of
by grady822
Truvada. as pre-exposure prophylaxis. Iain Reeves...
METHODS Conclusion INTRODUCTION
METHODS Conclusion INTRODUCTION
by anderson
ACKNOWLEDGEMENTS. REFERENCES. Leslie . Dunc...
The Effect of Semaglutide on Kidney Function: Post-Hoc Analysis of Three Randomized Controlled Tria
The Effect of Semaglutide on Kidney Function: Post-Hoc Analysis of Three Randomized Controlled Tria
by berey
Metabolic Dysfunction-Associated Steatotic Liver D...
Prise en charge des patients
Prise en charge des patients
by ethlyn
insuffisants cardiaques ET insuffisants rénaux :....
CLINICAL EXPERIENCE OF NSCLC in RSDM
CLINICAL EXPERIENCE OF NSCLC in RSDM
by sophia
Ana Rima. PENDAHULUAN. 2. Kanker Paru. P. enyebab ...
BackgroundAcutekidneyinjuryAKIischaracterizedbyelevatedserumcreatini
BackgroundAcutekidneyinjuryAKIischaracterizedbyelevatedserumcreatini
by udeline
invasiveandnon-invasivemeasurementofintraoperative...
Downloaded from httprupressorgjcbarticlepdf120185125596185
Downloaded from httprupressorgjcbarticlepdf120185125596185
by rodriguez
Downloaded from http://rupress.org/jcb/article-pdf...
KidneyFundorg HelpLineKidneyFundorg
KidneyFundorg HelpLineKidneyFundorg
by desha
eGFR teststimated iltration ate(blood creatinine t...
A GLP-1 Receptor Agonist CV Outcomes Trial
A GLP-1 Receptor Agonist CV Outcomes Trial
by BadassBabe
Final Results. Background. Trends in the Prevalenc...
Jchem applications in Medchem
Jchem applications in Medchem
by StarsAndStripes
Prediction. . and. . Data Sorting. Zhengtao. Li...
2018 Annual Data Report Volume 1: Chronic Kidney Disease
2018 Annual Data Report Volume 1: Chronic Kidney Disease
by melody
2018 Annual Data Report . Volume 1 CKD, Chapter 1...
Diabetic nephropathy s.Jafary
Diabetic nephropathy s.Jafary
by singh
. nodushan. Fellow of endocrinology. R...
Product data sheet
Product data sheet
by dorothy
MedKoo Biosciences http//wwwmedkoocomsalesmedkooc...
1 Supplemental Figure S1
1 Supplemental Figure S1
by susan2
Figure S1. . Examples of images showing mRFP-LC3B ...
Mechanistic Insights into Oncogenic Activation of Epidermal
Mechanistic Insights into Oncogenic Activation of Epidermal
by ripplas
Growth Factor Receptor (EGFR) mutants and its Clin...
Please note, these are the
Please note, these are the
by markes
actual. . video-recorded proceedings from the . l...
p=0.83 Supplementary Figure 1: Effect of whole body irradiation (WBI) on local tumour control for S
p=0.83 Supplementary Figure 1: Effect of whole body irradiation (WBI) on local tumour control for S
by laxreffa
. . Dose response curves after single dose (SD) ap...
Lung cancer Treatment
Lung cancer Treatment
by attentionallianz
Consequences of the Lack of Patients of color &...
Please note, these are the actual video-recorded
Please note, these are the actual video-recorded
by chaptoe
proceedings from the live CME event and may includ...
Chapter 1: CKD in the General Population
Chapter 1: CKD in the General Population
by stefany-barnette
Chapter 1: CKD in the General Population 2017 An...
Josep Tabernero, MD PhD Medical Oncology Department Vall
Josep Tabernero, MD PhD Medical Oncology Department Vall
by test
Josep Tabernero, MD PhD Medical Oncology Depa...
Challenges in RAS Wild-Type mCRC
Challenges in RAS Wild-Type mCRC
by marina-yarberry
Introduction. Decision-Making Algorithm for First...
Data Source: National Health and Nutrition Examination Survey (NHANES), 1999-2002, 2003-2006, 2007
Data Source: National Health and Nutrition Examination Survey (NHANES), 1999-2002, 2003-2006, 2007
by kittie-lecroy
.. . 2016 Annual Data Report, Vol 1, CKD, . Ch....
2 Vol 1, CKD, Ch 1 vol
2 Vol 1, CKD, Ch 1 vol
by liane-varnes
1 Table 1.1 Distribution of NHANES participants...
Chronic Kidney Disease The Basics
Chronic Kidney Disease The Basics
by stefany-barnette
Kevin Harley, M.D.. Assistant Clinical Professor....
Figure 1.1 Distribution of NHANES participants with diabetes, self-reported cardiovascular diseas
Figure 1.1 Distribution of NHANES participants with diabetes, self-reported cardiovascular diseas
by trish-goza
Vol 1, CKD, Ch 1. 2. Data Source: National Health...
The Epidermal Growth Factor Receptor Regulates
The Epidermal Growth Factor Receptor Regulates
by debby-jeon
Cofilin. Activity and Promotes Transmissible Gas...